Korean J Transplant.  2021 Dec;35(4):257-261. 10.4285/kjt.21.0029.

Heart transplantation in a patient with complex heart lung disease: a case report

Affiliations
  • 1Division of Cardiology, Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea

Abstract

Heart disease is often accompanied by lung disease as they share the same risk factors. Heart or lung transplantation is regarded as a definitive treatment for the end-stage disease of each, while the expected median survival for lung transplantation is far shorter than heart transplantation. We present a case of refractory heart failure along with severe obstructive and restrictive lung disease that showed dramatic improvement in pulmonary function after single heart transplantation.

Keyword

Heart transplantation; Heart failure; Pulmonary function test; Lung transplantation; Case report

Figure

  • Fig. 1 (A) Chest radiograph. (B) Initial electrocardiogram. (C) Still image of echocardiography. (D) Chest computed tomography.

  • Fig. 2 Serial pulmonary function test results. FVC, forced vital capacity; PRED, predicted; FEV, forced expiratory volume; DLCO, diffusing capacity for carbon monoxide; PRE, pre-bronchodilator; POST, post-bronchodilator.


Reference

1. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ. 2009; Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 11:130–9. DOI: 10.1093/eurjhf/hfn013. PMID: 19168510. PMCID: PMC2639415.
Article
2. Boudestein LC, Rutten FH, Cramer MJ, Lammers JW, Hoes AW. 2009; The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail. 11:1182–8. DOI: 10.1093/eurjhf/hfp148. PMID: 19887495.
Article
3. McCullough PA, Hollander JE, Nowak RM, Storrow AB, Duc P, Omland T, et al. 2003; Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med. 10:198–204. DOI: 10.1197/aemj.10.3.198. PMID: 12615582.
Article
4. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, et al. 2005; Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 26:1887–94. DOI: 10.1093/eurheartj/ehi291. PMID: 15860516.
Article
5. Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D Jr, Hsich E, et al. 2019; The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019 focus theme: donor and recipient size match. J Heart Lung Transplant. 38:1056–66. DOI: 10.1016/j.healun.2019.08.004. PMID: 31548031. PMCID: PMC6816343.
Article
6. Naum CC, Sciurba FC, Rogers RM. 1992; Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation. Am Rev Respir Dis. 145:1334–8. DOI: 10.1164/ajrccm/145.6.1334. PMID: 1595999.
Article
7. Wasserman K, Zhang YY, Gitt A, Belardinelli R, Koike A, Lubarsky L, et al. 1997; Lung function and exercise gas exchange in chronic heart failure. Circulation. 96:2221–7. DOI: 10.1161/01.CIR.96.7.2221. PMID: 9337193.
Article
8. Cardiac asthma. Lancet. 1990; 335:693–4. DOI: 10.1016/0140-6736(90)90807-H.
9. Hosenpud JD, Stibolt TA, Atwal K, Shelley D. 1990; Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am J Med. 88:493–6. DOI: 10.1016/0002-9343(90)90428-G. PMID: 2337106.
Article
10. Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, Kübler W, et al. 2001; Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation. 103:2153–8. DOI: 10.1161/01.CIR.103.17.2153. PMID: 11331255.
11. Guazzi M. 2003; Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role. Chest. 124:1090–102. DOI: 10.1378/chest.124.3.1090. PMID: 12970042.
12. Gehlbach BK, Geppert E. 2004; The pulmonary manifestations of left heart failure. Chest. 125:669–82. DOI: 10.1378/chest.125.2.669. PMID: 14769751.
Article
13. Drakos SG, Kfoury AG, Gilbert EM, Horne BD, Long JW, Stringham JC, et al. 2007; Effect of reversible pulmonary hypertension on outcomes after heart transplantation. J Heart Lung Transplant. 26:319–23. DOI: 10.1016/j.healun.2007.01.012. PMID: 17403471.
Article
14. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. 1988; Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 7:331–6. PMID: 3058901.
Full Text Links
  • KJT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr